Rastogi P, Bandos H, Lucas PC, van 't Veer LJ, et al. Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. J Clin Oncol 2024;42:3561-3569.
PMID: 39047219